Watchlist Price Alert

MERCK Kommanditgesellscha... (MKKGY)

OTC: MKKGY · Real-Time Price · USD

26.15

0.21 (0.81%)

At close: Jul 01, 2025, 9:33 AM

0.81% (1D)

Bid	26.03
Market Cap	56.3B
Revenue (ttm)	21.16B
Net Income (ttm)	2.78B
EPS (ttm)	1.49
PE Ratio (ttm)	17.55
Forward PE	12.69
Analyst	n/a

Ask	26.09
Volume	202
Avg. Volume (20D)	152,990
Open	26.04
Previous Close	25.94
Day's Range	26.04 - 26.15
52-Week Range	24.32 - 39.17
Beta	0.64

About MKKGY

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MKKGY

Website n/a

Full Company Profile

News

Just now · businesswire.com

Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that it has closed the acquisition of SpringWorks Therapeutics, Inc., for...

2 weeks ago · businesswire.com

China's Center for Drug Evaluation Accepts Merck KGaA, Darmstadt, Germany's Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell Tumor

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical P...

1 month ago · seekingalpha.com

Merck KGaA (MKGAF) Q1 2025 Earnings Call Transcript

Merck KGaA (OTCPK:MKGAF) Q1 2025 Earnings Call May 15, 2025 8:00 AM ET Company Participants Florian Schraeder - Head, Investor Relations Belen Garijo - Group Chief Executive Officer Helene von Roeder ...

1 month ago · reuters.com

Germany's Merck drops China surcharge on orders after US-China tariff deal

German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China following the U.S.-China agreement to pause sky-high tariffs on each other, the com...

2 months ago · zacks.com

MKKGY vs. ZTS: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Drugs sector have probably already heard of Merck KGaA (MKKGY) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang fo...

2 months ago · proactiveinvestors.co.uk

Merck KGaA swoops for US group SpringWorks in $3.4bn deal

Germany's Merck KGaA has agreed to acquire US biotech firm SpringWorks Therapeutics for $3.9 billion in cash. The deal, announced on Monday, values SpringWorks at $47 a share and reflects an enterpris...

2 months ago · wsj.com

Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal

The deal to acquire the U.S. biopharmaceutical company confirms an earlier report in The Wall Street Journal.

2 months ago · reuters.com

Germany's Merck KGaA in $3.9 bln deal to acquire US biotech firm SpringWorks

German healthcare and materials group Merck KGaA said on Monday it struck a deal to acquire U.S. biotech firm SpringWorks Therapeutics for an equity value of $3.9 billion to boost its cancer drug busi...